Track topics on Twitter Track topics that are important to you
PALM BEACH, Florida, August 10, 2017 /PRNewswire/ --
As the cannabis industry continues to grow across North America and consumer demand rises, the need for improved operations, new products and more proficient extraction, processing and grow facilities are creating unique revenue opportunities in numerous areas in the U.S. and Canada where the plant is now legal, both recreationally and medicinally. Active companies in the industry include Future Farm Technologies Inc. (OTC: FFRMF) (CSE: FFT), PotNetwork Holding Inc. (OTC: POTN), UbiquiTECH Software Corp. (OTC: UBQU), Canopy Growth Corporation (TSX: WEED.TO) (OTC: TWMJF) and Aphria Inc. (TSX: APH.TO) (OTC: APHQF)
Future Farm Technologies Inc. (CSE: FFT) (OTCQB: FFRMF) is pleased to announce that a video of the previously announced California extraction facility is now online and available for viewing. Investors are encouraged to view the Company's progress by clicking on the following link: Future Farm Extraction Video: https://youtu.be/7_BueNu6-5Y.
The extraction equipment is designed to be able to rapidly scale the manufacture of premium cannabis oil to supply the growing demand for cannabis concentrates in the state of California. The equipment utilizes a closed-loop system to produce high quality oil in a high throughput system with minimal maintenance and labor. Read this and more news for Future Farm at: http://www.marketnewsupdates.com/news/ffrmf.html.
"We believe this alcohol extraction technology is the best extraction equipment on the market today," says William Gildea, CEO of Future Farm. "The ability to process large amounts of cannabis flower into highly purified concentrates from day one will immediately benefit California's medical marijuana community."
Cannabis concentrates and edibles are the largest and fastest growing segments of the cannabis market, which many experts believe will overtake cannabis whole flower sales by 2020. The market for cannabis concentrates is booming because they are used to make edibles, topical ointments, capsules and other packaged products that require consistent, precise, and high quality oils, obtained from professional extraction methods. As the recreational industry begins to bud in California, many in the concentrates niche believe it's going to continue to explode in popularity.
In additional news and developments:
PotNetwork Holding Inc. (OTC: POTN) announced today, in consideration of management's strategy to formulate, produce, and market a spectrum of exclusive and diversely targeted cannabidiol blends, PotNetwork Holding has formed an advisory board to provide Diamond CBD with guidance and insight on upcoming formulations. Ultimately planned to consist of physicians and medical cannabis specialists, the first appointment was the distinguished Dr. Mark G. Sabbota.
Dr. Sabbota's credentials include Board Certification in both Internal Medicine and Cardiology. He brings to the Company a wealth of experience and is expected to be a valued contributor, having a comprehensive understanding of Cannabinoid attributes and corresponding knowledge based on research studies, along with Controlled Substance and DEA Licensure. "We want to extend an enthusiastic welcome to Dr. Sabbota and look forward to having his insight as we continue the development of our targeted product lines. We're developing a diverse and hand selected committee of professionals that will strengthen our competitive advantage by providing valuable cutting-edge guidance, and look forward with great anticipation to future growth with the contributions by the accomplished and esteemed Dr. Sabbota, and fellow experts joining our Board," stated Maria Gomez, Regional Vice President of Sales of Diamond CBD, Inc.
"I am looking forward to extensive collaboration with the Diamond CBD team. It's an advantageous time to be involved with such a visionary and motivated group. Diamond CBD's formulas are premium and revolutionary. To be on board with a team so diligent and focused on leading in the industry is an exciting endeavor," stated Mark G. Sabbota, Doctor of Osteopathic Medicine. Dr. Sabbota received his medical degree from Chicago College of Osteopathic Medicine, at Midwestern University. He completed a transitional internship and internal medicine residency and cardiology fellowship at Botsford General Hospital. Dr. Sabbota completed additional training in cardiology at the University of Michigan.
UbiquiTECH Software Corp. (OTC: UBQU) closed up 18.84% on Wednesday with over 11.7 million shares traded by the market close. The company, through its operating subsidiary HempLifeToday™, recently announced its newest product line to be sold on the new HempLifeToday.com Website. New CannazALL Pets™ will feature CannazALL™ CBD products formulated specifically for pets and will be available within the next 30-60 days. According to the APPA (American Pet Products Association), US residents spent over 60 billion dollars on pet products in 2015, up from 58 billion in 2014, and the trend is growing. Of this amount (in 2015), approximately 15 billion was spent on pet medications alone, and this is the multi-billion dollar market the Company expects CannazALL Pets™ to tap into.
Canopy Growth Corporation (TSX: WEED.TO) (OTC: TWMJF) recently announced an agreement with Umbral Energy Corp. (CSE: UMB). If and when the appropriate cultivation and sales licences have been granted, Umbral's 75% owned subsidiary, PheinMed Inc. ("PheinMed"), a late stage applicant under Health Canada's ACMPR regulations, will supply its cannabis products via TweedMainStreet.com, the most diverse cannabis marketplace in Canada. The agreement will serve to increase the amount of variety and consistency of supply available to Tweed's registered medical cannabis customers.
Aphria Inc. (TSX: APH.TO) (OTC: APHQF) recently announced that it entered into a global strategic partnership with Nuuvera Corp. ("Nuuvera"), a Canadian-based global cannabis business. Initially focused on the Canadian market, the partnership includes joint relationships with Nuuvera to expand production across the globe, including Europe , Israel and Latin America. "This is an exciting strategic partnership for Aphria and Nuuvera. By combining our unparalleled experience in cannabis production with Nuuvera's extensive international network, we will bring the best of two leaders to meet the growing global demand for cannabis," said Vic Neufeld , Chief Executive Officer, Aphria. "This partnership is further recognition by the global cannabis industry of the strength of our greenhouse growing intellectual property, and of Aphria's strategy to monetize it, in order to create additional shareholder value. We look forward to building a long-term partnership with Nuuvera to create an even more valuable presence in the market."
DISCLAIMER: MarketNewsUpdates.com (MNU) is a third party publisher and news dissemination service provider, which disseminates electronic information through multiple online media channels. MNU is NOT affiliated in any manner with any company mentioned herein. MNU and its affiliated companies are a news dissemination solutions provider and are NOT a registered broker/dealer/analyst/adviser, holds no investment licenses and may NOT sell, offer to sell or offer to buy any security. MNU's market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities. The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material. All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks. All material included herein is republished content and details which were previously disseminated by the companies mentioned in this release. MNU is not liable for any investment decisions by its readers or subscribers. Investors are cautioned that they may lose all or a portion of their investment when investing in stocks. For current services performed MNU has been compensated twenty-four hundred dollars for news coverage of the current press release issued by Future Farm Technologies Inc by a non-affiliated third party. MNU HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.
This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company's annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and MNU undertakes no obligation to update such statements.
SOURCE MarketNewsUpdates.comNEXT ARTICLE
The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...
Cardiology is a specialty of internal medicine. Cardiac electrophysiology : Study of the electrical properties and conduction diseases of the heart. Echocardiography : The use of ultrasound to study the mechanical function/physics of the h...